Last reviewed · How we verify
TD Vaccine System
The TD Vaccine System induces an immune response against specific pathogens.
The TD Vaccine System induces an immune response against specific pathogens. Used for Protection against certain infectious diseases.
At a glance
| Generic name | TD Vaccine System |
|---|---|
| Sponsor | Intercell USA, Inc. |
| Modality | Biologic |
| Therapeutic area | Immunology |
| Phase | Phase 3 |
Mechanism of action
This is achieved through the administration of a vaccine that stimulates the body's immune system to produce antibodies and immune cells that can recognize and fight specific pathogens. The vaccine contains antigens that are derived from the pathogens, which are then processed by the immune system to trigger an immune response.
Approved indications
- Protection against certain infectious diseases
Common side effects
- Pain, redness, or swelling at the injection site
Key clinical trials
- Adoptive Cellular Therapy in Pediatric Patients With High-grade Gliomas (PHASE1)
- PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma (PHASE2)
- SOP Toolkit in Diverse Practices Implemented & Tested With RE-AIM (NA)
- Interleukin-2 Plus Anti-HIV Therapy in HIV-Infected Children With Weakened Immune Systems (PHASE1)
- LT Vaccine Patch Self-Administration Study (PHASE2)
- Traveler's Diarrhea (TD) Automated Process (PHASE2)
- Study of Adolescent Immunization Recall Systems (NA)
- Improving the Immune System With Human IL-7 Vaccine in Older Subjects Who Have Had Chemotherapy (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |